Unibest 优贝德
← Back to patent-cliff list

CAS 2095840-80-3

N-(3-((2-chlorothieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylamide

Codes:OLMU-012

Application context (from source-drug indications)

非小细胞肺癌奥莫替尼

Source drugs (routes using this intermediate)

DrugTierExpiry
奥莫替尼OlmutinibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

奥莫替尼优化路线steps: 2total yield: 50.6 g (Olmutinib)
2,4-dichlorothieno[3,2-d]pyrimidine→4-(4-methylpiperazin-1-yl)aniline→N-(3-hydroxyphenyl)acrylamide→N-(3-((2-chlorothieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylamide

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.